Evoke Pharma Inc
EVOKDelisted Dec 17, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001403708
Evoke Pharma Inc was delisted on Dec 17, 2025; its insiders filed their last Form 4 on Dec 19, 2025; 15 institutions reported holding it in 13F filings for Q3 2025, worth $2.94M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Evoke Pharma Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- 0 vs. Q2 2023
- Shares held
- 67.2K
- +7.99K (+13.5%) vs. Q2 2023
- Total value
- $92.4K
- −$5.01K (−5.1%) vs. Q2 2023
- New holders
- 0
- 4 more added
- Sold out
- 0
- 0 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EVOK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 15 | $2.94M |
| Q2 2025 | 10 | $603.6K |
| Q1 2025 | 10 | $678.2K |
| Q4 2024 | 8 | $965.6K |
| Q3 2024 | 12 | $994.6K |
| Q2 2024 | 16 | $1.67M |
| Q1 2024 | 15 | $1.93M |
| Q4 2023 | 11 | $71.8K |
| Q3 2023 | 11 | $92.4K |
| Q2 2023 | 11 | $97.4K |
| Q1 2023 | 12 | $131.1K |
| Q4 2022 | 12 | $161.2K |
| Q3 2022 | 11 | $117.0K |
| Q2 2022 | 13 | $228.0K |
| Q1 2022 | 22 | $987.0K |
| Q4 2021 | 25 | $1.13M |
| Q3 2021 | 23 | $5.46M |
| Q2 2021 | 22 | $6.17M |
| Q1 2021 | 25 | $7.83M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Evoke Pharma Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 29,851 | $41.2K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 27,065 | $37.1K | 0.00% | +6,171+29.5% | Added |
| Tower Research Capital LLC (TRC) | 5,793 | $7.99K | 0.00% | +213+3.8% | Added |
| UBS Group AG | 2,707 | $3.74K | 0.00% | +1,600+144.5% | Added |
| BlackRock Inc. | 1,473 | $2.03K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 208 | $287 | 0.00% | 00.0% | Unchanged |
| Concord Wealth Partners | 31 | $43 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 24 | $33 | 0.00% | +7+41.2% | Added |
| Federation des caisses Desjardins du Quebec | 5 | $7 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 28 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 16 | $0 | 0.00% | 00.0% | Unchanged |